DMAC2L
gene geneOn this page
Also known as HSU79253ATPW
Summary
DMAC2L (distal membrane arm assembly component 2 like, HGNC:18799) is a protein-coding gene on chromosome 14q21.3, encoding ATP synthase subunit s, mitochondrial (Q99766). Involved in regulation of mitochondrial membrane ATP synthase.
This gene encodes a subunit of mitochondrial ATP synthase. Mitochondrial ATP synthase catalyzes ATP synthesis, utilizing an electrochemical gradient of protons across the inner membrane during oxidative phosphorylation. ATP synthase is composed of two linked multi-subunit complexes: the soluble catalytic core, F1, and the membrane-spanning component, Fo, comprising the proton channel. This gene encodes the subunit s, also known as factor B, of the proton channel. This subunit is necessary for the energy transduction activity of the ATP synthase complexes. Alternatively spliced transcript variants encoding different isoforms have been identified.
Source: NCBI Gene 27109 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 65 total — 1 pathogenic, 1 likely-pathogenic
- GTEx eGene: eQTL in 41 tissues, sQTL in 22 (q < 0.05)
- Constraint (gnomAD): pLI 0.00 (LoF-tolerant), LOEUF 1.31 (unconstrained)
- MANE Select transcript:
NM_001382507 - Notable: 65 clinical variants but no curated precision-oncology (CIViC) evidence yet
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:18799 |
| Approved symbol | DMAC2L |
| Name | distal membrane arm assembly component 2 like |
| Location | 14q21.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | HSU79253, ATPW |
| Ensembl gene | ENSG00000125375 |
| Ensembl biotype | protein_coding |
| OMIM | 618579 |
| Entrez | 27109 |
Gene structure
Transcript identifiers
Ensembl transcripts: 37 — 32 protein_coding, 3 nonsense_mediated_decay, 1 protein_coding_CDS_not_defined, 1 retained_intron
MANE Select: ENST00000557421
Transcript support level (Ensembl TSL; 1 = fully mRNA-supported): TSL 1: 5, TSL 2: 2, TSL 3: 3, TSL 5: 1
ENST00000557421, ENST00000245448, ENST00000311459, ENST00000358473, ENST00000426751, ENST00000553774, ENST00000554204, ENST00000554438, ENST00000554951, ENST00000555939, ENST00000556962, ENST00000672419, ENST00000672910, ENST00000904299, ENST00000904300, ENST00000904301, ENST00000929463, ENST00000929464, ENST00000929465, ENST00000992705, ENST00000992706, ENST00001051909, ENST00001059430, ENST00001059431, ENST00001105260, ENST00001105261, ENST00001105262, ENST00001105263, ENST00001106859, ENST00001121757, ENST00001121758, ENST00001121759, ENST00001121760, ENST00001128054, ENST00001130508, ENST00001130509, ENST00001133372
RefSeq mRNA: 7 — MANE Select: NM_001382507
NM_001003803, NM_001003805, NM_001370605, NM_001382507, NM_001382509, NM_001382510, NM_015684
CCDS: CCDS32075, CCDS32076, CCDS45102
Canonical transcript exons
ENST00000557421 — 6 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002465857 | 50325609 | 50327957 |
| ENSE00002469347 | 50312324 | 50312389 |
| ENSE00002496144 | 50314591 | 50314626 |
| ENSE00003502536 | 50323945 | 50324116 |
| ENSE00003603634 | 50322511 | 50322719 |
| ENSE00003814712 | 50321483 | 50321594 |
Expression profiles
Bgee: expression breadth ubiquitous, 294 present calls, max score 95.31.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 7.6762 / max 75.1101, expressed in 1748 samples.
Highest expression (Bgee): sperm, uterine tube, male germ cell, skeletal muscle tissue of biceps brachii, biceps brachii.
Genetic regulation across tissues (GTEx eQTL / sQTL)
DMAC2L is an eGene in GTEx v10 — its expression is genetically regulated (eQTL) in 41 tissues and its splicing (sQTL) in 22 (q < 0.05). Strongest associations first; slope = normalized effect of the lead variant’s alternative allele.
showing 20 of 63 significant tissue × QTL associations:
| Tissue | QTL | q-value | Slope | Lead variant |
|---|---|---|---|---|
| Heart Atrial Appendage | eqtl | 5.2e-72 | -0.66 | 14:50322323:C:T |
| Testis | sqtl | 2.0e-69 | +1.14 | 14:50312098:A:C |
| Muscle Skeletal | eqtl | 6.0e-57 | -0.39 | 14:50312098:A:C |
| Heart Left Ventricle | eqtl | 2.1e-54 | -0.45 | 14:50312098:A:C |
| Esophagus Muscularis | eqtl | 1.3e-30 | -0.39 | 14:50312098:A:C |
| Colon Transverse | eqtl | 1.8e-21 | -0.31 | 14:50317180:G:T |
| Esophagus Gastroesophageal Junction | eqtl | 1.6e-20 | -0.42 | 14:50322323:C:T |
| Skin Sun Exposed Lower leg | eqtl | 9.1e-20 | -0.24 | 14:50312098:A:C |
| Testis | eqtl | 3.6e-18 | -0.20 | 14:50318201:C:A |
| Muscle Skeletal | sqtl | 1.2e-17 | +1.72 | 14:50312363:G:GCTCCCTCCCTCC |
| Colon Sigmoid | eqtl | 2.5e-17 | -0.31 | 14:50322383:A:AATAC |
| Thyroid | eqtl | 6.3e-16 | -0.24 | 14:50317093:A:G |
| Stomach | eqtl | 1.1e-12 | -0.23 | 14:50322323:C:T |
| Artery Tibial | eqtl | 3.7e-12 | -0.24 | 14:50322383:A:AATAC |
| Adipose Visceral Omentum | eqtl | 5.8e-12 | -0.16 | 14:50317180:G:T |
| Cells Cultured fibroblasts | eqtl | 9.1e-12 | -1.08 | 14:50312363:G:GCTCCCTCCCTCC |
| Adipose Subcutaneous | eqtl | 2.2e-11 | -0.17 | 14:50318201:C:A |
| Brain Frontal Cortex BA9 | eqtl | 1.4e-10 | -0.35 | 14:50340005:G:A |
| Skin Not Sun Exposed Suprapubic | eqtl | 3.2e-10 | -0.19 | 14:50309523:C:T |
| Esophagus Mucosa | eqtl | 7.6e-10 | -0.16 | 14:50321495:C:T |
FANTOM5 promoters
3 alternative TSS:
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 139489 | 5.8255 | 1683 |
| 139490 | 1.8359 | 1037 |
| 139488 | 0.0148 | 5 |
Top tissues by expression
showing 100 of 297 tissues by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| sperm | CL:0000019 | 95.31 | gold quality |
| right uterine tube | UBERON:0001302 | 94.19 | gold quality |
| male germ cell | CL:0000015 | 93.58 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 93.24 | gold quality |
| biceps brachii | UBERON:0001507 | 93.18 | gold quality |
| endothelial cell | CL:0000115 | 92.58 | gold quality |
| triceps brachii | UBERON:0001509 | 92.56 | gold quality |
| gluteal muscle | UBERON:0002000 | 91.28 | gold quality |
| oocyte | CL:0000023 | 91.25 | gold quality |
| diaphragm | UBERON:0001103 | 90.93 | gold quality |
| adult organism | UBERON:0007023 | 90.90 | gold quality |
| heart right ventricle | UBERON:0002080 | 89.88 | gold quality |
| upper leg skin | UBERON:0004262 | 89.88 | gold quality |
| right testis | UBERON:0004534 | 89.71 | gold quality |
| penis | UBERON:0000989 | 89.70 | gold quality |
| left testis | UBERON:0004533 | 89.67 | gold quality |
| muscle of leg | UBERON:0001383 | 89.61 | gold quality |
| gastrocnemius | UBERON:0001388 | 89.58 | gold quality |
| muscle organ | UBERON:0001630 | 89.40 | gold quality |
| vastus lateralis | UBERON:0001379 | 89.18 | gold quality |
| endometrium epithelium | UBERON:0004811 | 88.98 | gold quality |
| oral cavity | UBERON:0000167 | 88.83 | gold quality |
| testis | UBERON:0000473 | 88.66 | gold quality |
| monocyte | CL:0000576 | 88.62 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 88.62 | gold quality |
| mononuclear cell | CL:0000842 | 88.54 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 88.44 | gold quality |
| quadriceps femoris | UBERON:0001377 | 88.37 | gold quality |
| leukocyte | CL:0000738 | 88.08 | gold quality |
| skin of hip | UBERON:0001554 | 87.78 | gold quality |
| ectocervix | UBERON:0012249 | 87.72 | gold quality |
| esophagus squamous epithelium | UBERON:0006920 | 87.39 | gold quality |
| endocervix | UBERON:0000458 | 87.25 | gold quality |
| pigmented layer of retina | UBERON:0001782 | 87.20 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 87.16 | gold quality |
| body of uterus | UBERON:0009853 | 87.08 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 86.80 | gold quality |
| spinal cord | UBERON:0002240 | 86.77 | gold quality |
| epithelium of esophagus | UBERON:0001976 | 86.73 | gold quality |
| jejunum | UBERON:0002115 | 86.64 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 86.63 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 86.53 | gold quality |
| metanephros cortex | UBERON:0010533 | 86.39 | gold quality |
| jejunal mucosa | UBERON:0000399 | 86.37 | gold quality |
| nipple | UBERON:0002030 | 86.07 | gold quality |
| secondary oocyte | CL:0000655 | 86.06 | gold quality |
| rectum | UBERON:0001052 | 85.93 | gold quality |
| muscle tissue | UBERON:0002385 | 85.89 | gold quality |
| eye | UBERON:0000970 | 85.80 | gold quality |
| prefrontal cortex | UBERON:0000451 | 85.48 | gold quality |
| palpebral conjunctiva | UBERON:0001812 | 85.35 | gold quality |
| corpus callosum | UBERON:0002336 | 85.33 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 85.21 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 85.16 | gold quality |
| uterine cervix | UBERON:0000002 | 85.10 | gold quality |
| adipose tissue | UBERON:0001013 | 85.10 | gold quality |
| bone marrow | UBERON:0002371 | 85.10 | gold quality |
| body of tongue | UBERON:0011876 | 85.03 | gold quality |
| thyroid gland | UBERON:0002046 | 84.97 | gold quality |
| fallopian tube | UBERON:0003889 | 84.94 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 84.93 | gold quality |
| connective tissue | UBERON:0002384 | 84.88 | gold quality |
| squamous epithelium | UBERON:0006914 | 84.74 | gold quality |
| ventral tegmental area | UBERON:0002691 | 84.73 | gold quality |
| cardiac ventricle | UBERON:0002082 | 84.50 | gold quality |
| superficial temporal artery | UBERON:0001614 | 84.44 | gold quality |
| heart left ventricle | UBERON:0002084 | 84.41 | gold quality |
| calcaneal tendon | UBERON:0003701 | 84.39 | gold quality |
| body of pancreas | UBERON:0001150 | 84.38 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 84.33 | gold quality |
| amygdala | UBERON:0001876 | 84.32 | gold quality |
| corpus epididymis | UBERON:0004359 | 84.30 | gold quality |
| subcutaneous adipose tissue | UBERON:0002190 | 84.28 | gold quality |
| sigmoid colon | UBERON:0001159 | 84.24 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 84.18 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 84.17 | gold quality |
| mammalian vulva | UBERON:0000997 | 84.12 | gold quality |
| uterus | UBERON:0000995 | 84.09 | gold quality |
| esophagus mucosa | UBERON:0002469 | 84.06 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 84.05 | gold quality |
| left ovary | UBERON:0002119 | 84.02 | gold quality |
| medial globus pallidus | UBERON:0002477 | 84.01 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 84.01 | gold quality |
| oviduct epithelium | UBERON:0004804 | 83.99 | gold quality |
| pharyngeal mucosa | UBERON:0000355 | 83.97 | gold quality |
| zone of skin | UBERON:0000014 | 83.93 | gold quality |
| cingulate cortex | UBERON:0003027 | 83.91 | gold quality |
| duodenum | UBERON:0002114 | 83.90 | gold quality |
| midbrain | UBERON:0001891 | 83.89 | gold quality |
| substantia nigra | UBERON:0002038 | 83.88 | gold quality |
| subthalamic nucleus | UBERON:0001906 | 83.82 | gold quality |
| deltoid | UBERON:0001476 | 83.77 | gold quality |
| endometrium | UBERON:0001295 | 83.76 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 83.76 | gold quality |
| right frontal lobe | UBERON:0002810 | 83.68 | gold quality |
| adrenal tissue | UBERON:0018303 | 83.66 | gold quality |
| inferior vagus X ganglion | UBERON:0005363 | 83.59 | gold quality |
| large intestine | UBERON:0000059 | 83.57 | gold quality |
| transverse colon | UBERON:0001157 | 83.53 | gold quality |
| colon | UBERON:0001155 | 83.52 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 9.60 |
HPA expression
RNA tissue specificity: Low tissue specificity
showing 60 of 76 HPA tissues / cells by nTPM:
| Tissue / cell | Axis | nTPM |
|---|---|---|
| Frontal cortex | tissue | 30.0 |
| Nucleus accumbens | tissue | 23.1 |
| Caudate putamen | tissue | 22.2 |
| Locus coeruleus | tissue | 21.6 |
| Hippocampus | tissue | 21.1 |
| Skeletal muscle | tissue | 20.8 |
| Postcentral gyrus | tissue | 20.6 |
| Choroid plexus | tissue | 17.7 |
| Tongue | tissue | 17.2 |
| Testis | tissue | 15.9 |
| Corpus callosum | tissue | 14.8 |
| Heart muscle | tissue | 14.0 |
| Spinal cord | tissue | 14.0 |
| Thyroid gland | tissue | 13.5 |
| Bone marrow | tissue | 13.3 |
| Medulla oblongata | tissue | 12.9 |
| Skin 1 | tissue | 12.4 |
| Midbrain | tissue | 12.4 |
| Parathyroid gland | tissue | 11.7 |
| Breast | tissue | 11.1 |
| Thalamus | tissue | 10.9 |
| Pons | tissue | 10.8 |
| Retina | tissue | 10.6 |
| Substantia nigra | tissue | 10.4 |
| Esophagus | tissue | 10.2 |
| Periaqueductal gray | tissue | 10.0 |
| Adipose tissue | tissue | 9.8 |
| Lymph node | tissue | 9.7 |
| Superior colliculi | tissue | 9.7 |
| Liver | tissue | 9.7 |
| Pancreas | tissue | 9.4 |
| Duodenum | tissue | 9.4 |
| Stomach 1 | tissue | 8.8 |
| Amygdala | tissue | 8.8 |
| Putamen | tissue | 8.7 |
| Hypothalamus | tissue | 8.7 |
| Small intestine | tissue | 8.5 |
| Septum | tissue | 8.5 |
| Ventral forebrain | tissue | 8.4 |
| Salivary gland | tissue | 8.3 |
| Epididymis | tissue | 8.3 |
| Hippocampal formation | tissue | 8.3 |
| Tonsil | tissue | 8.1 |
| Cerebral cortex | tissue | 7.9 |
| Rectum | tissue | 7.9 |
| Colon | tissue | 7.9 |
| Kidney | tissue | 7.9 |
| Somatosensory cortex | tissue | 7.9 |
| Temporal cortex | tissue | 7.9 |
| Occipital cortex | tissue | 7.8 |
| Prostate | tissue | 7.7 |
| Motor cortex | tissue | 7.5 |
| Entorhinal cortex | tissue | 7.4 |
| Fallopian tube | tissue | 7.4 |
| Urinary bladder | tissue | 7.3 |
| Retrosplenial and cingulate cortex | tissue | 7.3 |
| Retrosplenial cortex | tissue | 7.3 |
| Prefrontal cortex | tissue | 7.2 |
| Thymus | tissue | 6.9 |
| Basal ganglia | tissue | 6.7 |
Brain sub-regions (HPA Brain Atlas): detected in 189; highest nTPM — Parieto-temporal junction (white matter) (35.7), Temporal white matter (33.5), Corpus callosum, splenium (white matter) (32.1), Corpus callosum, genu (white matter) (31.2), Dorsal funiculus (white matter) (30.0).
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): MYC
miRNA regulators (miRDB)
Targeting DMAC2L by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific).
13 miRNAs:
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4476 | 100.00 | 68.18 | 2030 |
| HSA-MIR-6876-5P | 100.00 | 67.68 | 2126 |
| HSA-MIR-6768-5P | 99.92 | 67.36 | 1942 |
| HSA-MIR-1290 | 99.59 | 69.90 | 2079 |
| HSA-MIR-4721 | 99.26 | 66.05 | 818 |
| HSA-MIR-3922-5P | 98.77 | 66.53 | 1059 |
| HSA-MIR-921 | 97.09 | 66.45 | 562 |
| HSA-MIR-4662A-3P | 97.02 | 67.77 | 941 |
| HSA-MIR-514A-3P | 96.43 | 67.77 | 1048 |
| HSA-MIR-514B-3P | 96.43 | 67.77 | 1048 |
| HSA-MIR-10525-3P | 96.32 | 68.04 | 699 |
| HSA-MIR-1291 | 96.28 | 65.89 | 1224 |
| HSA-MIR-6775-3P | 95.76 | 65.91 | 982 |
Functional genomics
gnomAD constraint: pLI 4.8e-07, LOEUF 1.31, missense Z 0.515 — population loss-of-function intolerance (pLI ≥ 0.9 = LoF-intolerant; lower LOEUF = more constrained). gnomAD
Regional missense constraint (gnomAD RMC): no regional variation along ENST00000557421 — one region, missense o/e 0.97.
Literature-anchored findings (GeneRIF, showing 1)
- The study is the first to show that ATP5S is one of the target genes of miR-34a. (PMID:26385595)
Cross-species orthologs
6 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | dmac2l | ENSDARG00000012072 |
| mus_musculus | Dmac2l | ENSMUSG00000054894 |
| rattus_norvegicus | Dmac2l | ENSRNOG00000004893 |
| drosophila_melanogaster | CG10731 | FBGN0034081 |
| caenorhabditis_elegans | WBGENE00015460 | |
| caenorhabditis_elegans | WBGENE00050937 |
Mouse-model phenotypes
Observed phenotypes of the mouse ortholog (MGI:1915305) from MGI (Alliance of Genome Resources) — knockout/mutant phenotypes, ranked by annotation count. 1 distinct phenotype terms.
| Mouse phenotype (MP) | Records |
|---|---|
| narrow eye opening | 1 |
Additional cross-species homologs
Sequence homologs in species beyond Ensembl Compara’s model organisms, by Diamond local protein alignment (% sequence identity; best hit per species). Lower-identity rows are more distant homologs. The matched accessions’ gene symbols aren’t in biobtree yet, so each row shows the UniProt accession.
| Organism | UniProt | Identity | Method |
|---|---|---|---|
| Pongo abelii | Q5R9E6 | 99.0% | Diamond |
| Macaca fascicularis | Q4R5S4 | 93.0% | Diamond |
| Bos taurus | P22027 | 90.5% | Diamond |
Genomic neighbors (locus context)
Genes flanking this one on the chromosome (NCBI/Entrez gene neighborhood). Positional context only — some neighbors share regulatory elements (bidirectional promoters, antisense/overlapping transcripts), but chromosomal adjacency is not itself a functional relationship (see Interactions for that).
| Symbol | Type | Entrez |
|---|---|---|
| MIR4504 | ncRNA | 100616261 |
| MAP4K5 | protein-coding | 11183 |
| ATL1 | protein-coding | 51062 |
| L2HGDH | protein-coding | 79944 |
| CDKL1 | protein-coding | 8814 |
| LINC01599 | ncRNA | 196913 |
| SOS2 | protein-coding | 6655 |
| VCPKMT | protein-coding | 79609 |
| SAV1 | protein-coding | 60485 |
Protein
Protein identifiers
ATP synthase subunit s, mitochondrial — Q99766 (reviewed: Q99766)
Alternative names: ATP synthase-coupling factor B, Distal membrane arm assembly complex 2-like protein, Mitochondrial ATP synthase regulatory component factor B
All UniProt accessions (5): A0A5F9ZGZ2, A0A5K1VW82, A0A8I5KUF2, Q99766, G3V467
UniProt curated annotations — full annotation on UniProt →
Function. Involved in regulation of mitochondrial membrane ATP synthase. Necessary for H(+) conduction of ATP synthase. Facilitates energy-driven catalysis of ATP synthesis by blocking a proton leak through an alternative proton exit pathway.
Subunit / interactions. Homotetramer. Associates with ATP synthase.
Subcellular location. Mitochondrion. Mitochondrion inner membrane.
Similarity. Belongs to the ATP synthase subunit s family.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q99766-1 | 1 | yes |
| Q99766-2 | 2 | |
| Q99766-3 | 3 |
RefSeq proteins (7): NP_001003803, NP_001003805, NP_001357534, NP_001369436, NP_001369438, NP_001369439, NP_056499 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR032675 | LRR_dom_sf | Homologous_superfamily |
UniProt features (14 total): splice variant 4, repeat 4, binding site 2, transit peptide 1, chain 1, sequence variant 1, region of interest 1
Structure
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q99766-F1 | 91.27 | 0.85 |
Human Protein Atlas
Protein class: Predicted intracellular proteins
Protein evidence: Evidence at protein level
Subcellular location (HPA, imaging): mitochondria; nucleoplasm
Antibody reliability (HPA): IF approved
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Ligand- & substrate-binding residues (2)
| Position | Role |
|---|---|
| 59 | Mg(2+) |
| 93 | Mg(2+) |
Function
Pathways and Gene Ontology
Reactome pathways
2 curated (TAS) of 6; 0 disease pathways. Curated-first; evidence = TAS (manually curated) vs IEA (electronic inference).
6 pathways:
| ID | Pathway | Evidence |
|---|---|---|
| R-HSA-8949613 | Cristae formation | curated |
| R-HSA-163210 | Formation of ATP by chemiosmotic coupling | curated |
| R-HSA-1428517 | Aerobic respiration and respiratory electron transport | — |
| R-HSA-1430728 | Metabolism | — |
| R-HSA-1592230 | Mitochondrial biogenesis | — |
| R-HSA-1852241 | Organelle biogenesis and maintenance | — |
MSigDB gene sets: 147 (showing top):
GRUETZMANN_PANCREATIC_CANCER_DN, GOBP_ORGANOPHOSPHATE_METABOLIC_PROCESS, GOBP_NUCLEOSIDE_PHOSPHATE_BIOSYNTHETIC_PROCESS, GOBP_ORGANOPHOSPHATE_BIOSYNTHETIC_PROCESS, REACTOME_FORMATION_OF_ATP_BY_CHEMIOSMOTIC_COUPLING, GOBP_CARBOHYDRATE_DERIVATIVE_METABOLIC_PROCESS, GOBP_MONOATOMIC_CATION_TRANSPORT, PUJANA_CHEK2_PCC_NETWORK, GOBP_NUCLEOBASE_CONTAINING_SMALL_MOLECULE_METABOLIC_PROCESS, BROWNE_HCMV_INFECTION_48HR_DN, GOBP_ATP_BIOSYNTHETIC_PROCESS, GOBP_CARBOHYDRATE_DERIVATIVE_BIOSYNTHETIC_PROCESS, GOBP_NUCLEOSIDE_TRIPHOSPHATE_METABOLIC_PROCESS, GOBP_NUCLEOSIDE_TRIPHOSPHATE_BIOSYNTHETIC_PROCESS, BROWNE_HCMV_INFECTION_14HR_DN
GO Biological Process (3): ATP biosynthetic process (GO:0006754), proton transmembrane transport (GO:1902600), monoatomic ion transport (GO:0006811)
GO Molecular Function (3): proton transmembrane transporter activity (GO:0015078), metal ion binding (GO:0046872), protein binding (GO:0005515)
GO Cellular Component (4): cytoplasm (GO:0005737), mitochondrion (GO:0005739), mitochondrial inner membrane (GO:0005743), proton-transporting ATP synthase complex (GO:0045259)
Reactome top-level categories
4 top-level categories:
| Category | Pathways |
|---|---|
| Aerobic respiration and respiratory electron transport | 1 |
| Mitochondrial biogenesis | 1 |
| Metabolism | 1 |
| Organelle biogenesis and maintenance | 1 |
GO top-level categories
20 GO namespaces:
| Category | Terms |
|---|---|
| nucleoside triphosphate biosynthetic process | 1 |
| purine ribonucleotide biosynthetic process | 1 |
| purine ribonucleoside triphosphate biosynthetic process | 1 |
| ATP metabolic process | 1 |
| monoatomic cation transmembrane transport | 1 |
| transport | 1 |
| monoatomic cation transmembrane transporter activity | 1 |
| proton transmembrane transport | 1 |
| cation binding | 1 |
| binding | 1 |
| intracellular anatomical structure | 1 |
| cellular anatomical structure | 1 |
| cytoplasm | 1 |
| intracellular membrane-bounded organelle | 1 |
| organelle inner membrane | 1 |
| mitochondrial membrane | 1 |
| proton-transporting two-sector ATPase complex | 1 |
| cation channel complex | 1 |
| respiratory chain complex | 1 |
| catalytic complex | 1 |
Experimentally-supported GO annotations
GO terms backed by direct experimental evidence (ECO experimental codes) — 1 of 10 annotations. The rest are phylogenetic / computational / electronic (IEA).
1 experimentally-supported GO terms:
| GO term | NS | Evidence |
|---|---|---|
| mitochondrion | CC | high-throughput |
Protein interactions and networks
STRING
showing 16 of 898 interactions by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| DMAC2L | ATP5PD | O75947 | 577 |
| DMAC2L | ATP5MC3 | P48201 | 540 |
| DMAC2L | ATP5MC1 | P05496 | 534 |
| DMAC2L | ATP5F1B | P06576 | 489 |
| DMAC2L | ATP5F1C | P36542 | 489 |
| DMAC2L | COX7A2 | P14406 | 463 |
| DMAC2L | OXA1L | Q15070 | 433 |
| DMAC2L | COQ4 | Q9Y3A0 | 422 |
| DMAC2L | ATP5ME | P56385 | 421 |
| DMAC2L | NDUFA1 | O15239 | 413 |
| DMAC2L | ATP5PB | P24539 | 401 |
| DMAC2L | ATP5MC2 | Q06055 | 389 |
| DMAC2L | ATP5MF | P56134 | 388 |
| DMAC2L | ATP6V1H | Q9UI12 | 377 |
| DMAC2L | COQ8A | Q8NI60 | 370 |
| DMAC2L | DMRT2 | Q9Y5R5 | 370 |
Disease & clinical
Genetic variants
Variant evidence for DMAC2L: 65 ClinVar records (2 pathogenic / likely pathogenic); 1 GWAS association. Per-variant detail is on Sugi Variant.
ClinVar
65 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 1 |
| Likely pathogenic | 1 |
| Uncertain significance | 36 |
| Likely benign | 19 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (2)
Showing all 2 pathogenic / likely-pathogenic ClinVar records, ranked by ClinVar review status (expert panel → multiple submitters → single submitter), then by number of submitting labs.
| Variant ID | HGVS | Classification | Review | Submitters |
|---|---|---|---|---|
| 1342871 | NM_024884.3(L2HGDH):c.1A>G (p.Met1Val) | Pathogenic | criteria provided, multiple submitters, no conflicts | 2 |
| 2573619 | NM_024884.3(L2HGDH):c.140+2_140+8del | Likely pathogenic | criteria provided, single submitter | 1 |
Per-variant reference — Sugi Variant
Explore DMAC2L’s pathogenic and likely-pathogenic variants individually — each with its ClinVar classification and conditions, applied ACMG criteria (ClinGen expert panel, where curated), the calibrated in-silico predictors (AlphaMissense, REVEL, SaProt, conservation), gnomAD frequency, and the predictor-disagreement QC signal — on Sugi Variant.
SpliceAI
Top 10 splice-impact sites by Δscore (adjacent positions with the same effect merged into one range; 22 predictions of 639):
| Position(s) | Effect | Δscore | Sites |
|---|---|---|---|
| 14:50322502 | acceptor_gain | 1.0000 | |
| 14:50322507 | acceptor_gain | 1.0000 | |
| 14:50322509–50322510 | acceptor_loss | 1.0000 | 4 |
| 14:50322510 | acceptor_gain | 1.0000 | |
| 14:50322508 | acceptor_gain | 0.9900 | |
| 14:50322509 | acceptor_loss | 0.9900 | |
| 14:50322720–50322721 | donor_loss | 0.9900 | 6 |
| 14:50314311 | acceptor_gain | 0.9800 | |
| 14:50322722 | donor_loss | 0.9800 | 2 |
| 14:50312390–50312391 | donor_loss | 0.9700 | 4 |
HPA cancer prognostics
RNA cancer specificity: Low cancer specificity
Human Protein Atlas survival analysis — favorable = higher expression predicts better survival.
1 prognostic cancer types:
| Cancer | Prognostic | p-value |
|---|---|---|
| Kidney Renal Clear Cell Carcinoma (TCGA) | favorable | 6.27e-08 |
Disease associations
OMIM: gene MIM:618579 | disease phenotypes: MIM:236792
GenCC curated gene-disease
Mondo (1): L-2-hydroxyglutaric aciduria (MONDO:0009370)
Orphanet (1): L-2-hydroxyglutaric aciduria (Orphanet:79314)
GWAS associations
1 associations:
| Study | Trait | p-value |
|---|---|---|
| GCST002312_10 | Periodontal disease-related phenotype (Socransky) | 8e-6 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (CPIC guideline: no)
CTD chemical–gene interactions
36 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects cotreatment, decreases expression | 4 |
| entinostat | decreases expression, affects cotreatment | 2 |
| Acetaminophen | increases expression | 2 |
| Estradiol | increases expression, affects cotreatment, decreases expression | 2 |
| Smoke | decreases expression | 2 |
| GSK-J4 | decreases expression | 1 |
| dicrotophos | decreases expression | 1 |
| urushiol | increases expression | 1 |
| methylmercuric chloride | decreases expression | 1 |
| glycidyl methacrylate | decreases expression | 1 |
| trichostatin A | decreases expression | 1 |
| sulforaphane | decreases expression | 1 |
| sodium arsenite | affects cotreatment, decreases expression, increases abundance | 1 |
| cobaltous chloride | decreases expression | 1 |
| manganese chloride | affects cotreatment, decreases expression, increases abundance | 1 |
| beta-methylcholine | affects expression | 1 |
| K 7174 | increases expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, decreases expression | 1 |
| dorsomorphin | affects cotreatment, decreases expression | 1 |
| NSC 689534 | affects binding, decreases expression | 1 |
| Irinotecan | decreases expression | 1 |
| Sunitinib | increases expression | 1 |
| Vorinostat | decreases expression | 1 |
| Arsenic | affects cotreatment, decreases expression, increases abundance | 1 |
| Copper | affects binding, decreases expression | 1 |
| Coumestrol | decreases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Formaldehyde | decreases expression | 1 |
| Isoniazid | increases expression | 1 |
| Manganese | increases abundance, affects cotreatment, decreases expression | 1 |
Clinical trials (associated diseases)
Via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): L-2-hydroxyglutaric aciduria, periodontitis